Targeting and eradicating latent CNS reservoirs of HIV-1: original strategies and new models.
暂无分享,去创建一个
[1] T. Luedde,et al. In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation , 2023, Nature Medicine.
[2] M. Nair,et al. HIV Latency and Nanomedicine Strategies for Anti-HIV Treatment and Eradication , 2023, Biomedicines.
[3] Meritxell Huch,et al. Organoids , 2022, Nature Reviews Methods Primers.
[4] S. Lewin,et al. Shock and kill within the CNS: A promising HIV eradication approach? , 2022, Journal of leukocyte biology.
[5] H. Gendelman,et al. Animal models for studies of HIV‐1 brain reservoirs , 2022, Journal of leukocyte biology.
[6] K. Christian,et al. Using 2D and 3D pluripotent stem cell models to study neurotropic viruses , 2022, Frontiers in Virology.
[7] J. Karn,et al. Recruitment of the CoREST transcription repressor complexes by Nerve Growth factor IB-like receptor (Nurr1/NR4A2) mediates silencing of HIV in microglial cells , 2022, PLoS pathogens.
[8] N. Nasr,et al. Evolving Strategies to Eliminate the CD4 T Cells HIV Viral Reservoir via CAR T Cell Immunotherapy , 2022, Frontiers in Immunology.
[9] M. Boks,et al. Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids , 2022, Viruses.
[10] P. Lieberman,et al. Epigenetic Landscape of HIV-1 Infection in Primary Human Macrophage , 2022, Journal of virology.
[11] Aihua Liu,et al. Human Brain Organoids as an In Vitro Model System of Viral Infectious Diseases , 2022, Frontiers in Immunology.
[12] C. Schwartz,et al. Suicide Gene Therapy in Cancer and HIV-1 infection: an alternative to conventional treatments. , 2021, Biochemical pharmacology.
[13] R. Diaz,et al. Latency-associated DNA methylation patterns among HIV-1 infected individuals with distinct disease progression courses or antiretroviral virologic response , 2021, Scientific Reports.
[14] B. Clotet,et al. Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy , 2021, AIDS.
[15] O. Paulsen,et al. Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology , 2021, Nature Neuroscience.
[16] O. Gascuel,et al. Drug resistance mutations in HIV: new bioinformatics approaches and challenges. , 2021, Current opinion in virology.
[17] T. Pan,et al. Broadly neutralizing antibody-derived CAR-T cells reduce viral reservoir in HIV-1-infected individuals. , 2021, The Journal of clinical investigation.
[18] Seung‐Woo Cho,et al. Microfluidic device with brain extracellular matrix promotes structural and functional maturation of human brain organoids , 2021, Nature Communications.
[19] D. Langford,et al. Viruses, SUMO, and immunity: the interplay between viruses and the host SUMOylation system , 2021, Journal of NeuroVirology.
[20] M. Tyagi,et al. HIV-1 PERSISTENCE IN THE CNS: MECHANISMS OF LATENCY, PATHOGENESIS AND AN UPDATE ON ERADICATION STRATEGIES. , 2021, Virus research.
[21] A. Gavin,et al. APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes , 2021, bioRxiv.
[22] H. Fine,et al. Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research , 2021, mBio.
[23] Won Hyuk Jang,et al. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson’s disease Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment , 2021, Progress in Neurobiology.
[24] J. M. Wessels,et al. Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses , 2021, Frontiers in Immunology.
[25] D. Russell,et al. Lnc(ing)RNAs to the “shock and kill” strategy for HIV-1 cure , 2021, Molecular therapy. Nucleic acids.
[26] N. London,et al. Organoid and Spheroid Tumor Models: Techniques and Applications , 2021, Cancers.
[27] A. Danckaert,et al. Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier , 2020, mBio.
[28] Madeline A. Lancaster,et al. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids , 2020, Cell Stem Cell.
[29] S. Sant,et al. Modeling HIV-1 neuropathogenesis using three-dimensional human brain organoids (hBORGs) with HIV-1 infected microglia , 2020, Scientific Reports.
[30] M. Carrillo,et al. Engineering CAR T Cells to Target the HIV Reservoir , 2020, Frontiers in Cellular and Infection Microbiology.
[31] K. Roskin,et al. Comparative analysis of human microglial models for studies of HIV replication and pathogenesis , 2020, Retrovirology.
[32] M. Nonnemacher,et al. Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites , 2020, Molecular therapy. Nucleic acids.
[33] C. Schwartz,et al. Brain HIV-1 latently-infected reservoirs targeted by the suicide gene strategy , 2020, Virology journal.
[34] S. Daunert,et al. The Paradox of HIV Blood–Brain Barrier Penetrance and Antiretroviral Drug Delivery Deficiencies , 2020, Trends in Neurosciences.
[35] Madeline A. Lancaster,et al. Human CNS barrier-forming organoids with cerebrospinal fluid production , 2020, Science.
[36] Bilal Cakir,et al. Generation of Regionally Specified Human Brain Organoids Resembling Thalamus Development , 2020, STAR protocols.
[37] C. Van Lint,et al. Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage , 2020, Scientific Reports.
[38] Yong Gao,et al. Advances in Developing CAR T-Cell Therapy for HIV Cure , 2020, Frontiers in Immunology.
[39] J. Martinez-Picado,et al. Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report , 2020, The lancet. HIV.
[40] Richard Martin,et al. Characterization of HIV-1 uncoating in human microglial cell lines , 2020, Virology Journal.
[41] F. C. Bennett,et al. Neuroinflammation and EIF2 Signaling Persist despite Antiretroviral Treatment in an hiPSC Tri-culture Model of HIV Infection , 2020, Stem cell reports.
[42] A. Das,et al. CRISPR-Cas9 Dual-gRNA Attack Causes Mutation, Excision and Inversion of the HIV-1 Proviral DNA , 2020, Viruses.
[43] Ethan M. Goldberg,et al. Sliced Human Cortical Organoids for Modeling Distinct Cortical Layer Formation. , 2020, Cell stem cell.
[44] Alejandra Borjabad,et al. Prevention and treatment of HIV infection and cognitive disease in mice by innate immune responses , 2020, Brain, behavior, & immunity - health.
[45] D. Maric,et al. Productive HIV infection in astrocytes can be established via a non-classical mechanism. , 2020, AIDS.
[46] Le Guo,et al. HIV infection suppresses TLR3 activation‐mediated antiviral immunity in microglia and macrophages , 2020, Immunology.
[47] S. Sauer,et al. Self-Organizing 3D Human Trunk Neuromuscular Organoids. , 2020, Cell stem cell.
[48] S. Pașca,et al. Organoid and Assembloid Technologies for Investigating Cellular Crosstalk in Human Brain Development and Disease. , 2019, Trends in cell biology.
[49] J. Do,et al. Neural Lineage Differentiation From Pluripotent Stem Cells to Mimic Human Brain Tissues , 2019, Front. Bioeng. Biotechnol..
[50] N. Kootstra,et al. The Role of Macrophages in HIV-1 Persistence and Pathogenesis , 2019, Front. Microbiol..
[51] Paul M. George,et al. Controlling properties of human neural progenitor cells using 2D and 3D conductive polymer scaffolds , 2019, Scientific Reports.
[52] J. Clements,et al. Brain macrophages harbor latent, infectious simian immunodeficiency virus. , 2019, AIDS.
[53] J. Ananworanich,et al. Perspective on potential impact of HIV CNS latency on eradication. , 2019, AIDS.
[54] J. Karn,et al. Cross-talk between microglia and neurons regulates HIV latency , 2019, PLoS pathogens.
[55] S. Spector,et al. TREM-1 Protects HIV-1-Infected Macrophages from Apoptosis through Maintenance of Mitochondrial Function , 2019, mBio.
[56] Abhishek Srivastava,et al. Reproducing human and cross-species drug toxicities using a Liver-Chip , 2019, Science Translational Medicine.
[57] Gail A. Van Norman,et al. Limitations of Animal Studies for Predicting Toxicity in Clinical Trials , 2019, JACC. Basic to translational science.
[58] C. Van Lint,et al. Microglial Cells: The Main HIV-1 Reservoir in the Brain , 2019, Front. Cell. Infect. Microbiol..
[59] M. Bickle,et al. Viral Infections Exacerbate FUS-ALS Phenotypes in iPSC-Derived Spinal Neurons in a Virus Species-Specific Manner , 2019, Front. Cell. Neurosci..
[60] R. Soto-Rifo,et al. New Challenges of HIV-1 Infection: How HIV-1 Attacks and Resides in the Central Nervous System , 2019, Cells.
[61] M. Dimri,et al. Insights into the HIV Latency and the Role of Cytokines , 2019, Pathogens.
[62] H. Gendelman,et al. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice , 2019, Nature Communications.
[63] D. Volsky,et al. Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model , 2019, Scientific Reports.
[64] G. Ming,et al. Brain organoids: advances, applications and challenges , 2019, Development.
[65] Taina T. Immonen,et al. Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes , 2019, PLoS pathogens.
[66] M. Nair,et al. Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection , 2019, Scientific Reports.
[67] C. Rae,et al. HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection , 2019, AIDS.
[68] J. Martinez-Picado,et al. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation , 2019, Nature.
[69] M. Humbert,et al. Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants , 2019, Journal of Virology.
[70] Prabir Patra,et al. hESC-Derived Thalamic Organoids Form Reciprocal Projections When Fused with Cortical Organoids. , 2019, Cell stem cell.
[71] Z. Debyser,et al. Establishment of latent HIV-1 reservoirs: what do we really know? , 2019, Journal of virus eradication.
[72] Z. Debyser,et al. Insight in HIV Integration Site Selection Provides a Block-and-Lock Strategy for a Functional Cure of HIV Infection , 2018, Viruses.
[73] L. Dorrell,et al. Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction , 2018, Front. Immunol..
[74] M. Blurton-Jones,et al. Development and validation of a simplified method to generate human microglia from pluripotent stem cells , 2018, Molecular Neurodegeneration.
[75] Sean J. Miller. Astrocyte Heterogeneity in the Adult Central Nervous System , 2018, Front. Cell. Neurosci..
[76] Colby R. Maldini,et al. CAR T cells for infection, autoimmunity and allotransplantation , 2018, Nature Reviews Immunology.
[77] J. Karn,et al. The Glucocorticoid Receptor Is a Critical Regulator of HIV Latency in Human Microglial Cells , 2018, Journal of Neuroimmune Pharmacology.
[78] Laura Masullo,et al. Cerebral organoids at the air-liquid interface generate diverse nerve tracts with functional output , 2018, Nature Neuroscience.
[79] Michael S. Fernandopulle,et al. Transcription Factor–Mediated Differentiation of Human iPSCs into Neurons , 2018, Current protocols in cell biology.
[80] H. Gendelman,et al. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment , 2018, PLoS pathogens.
[81] M. Ato,et al. Introduction of Human Flt3-L and GM-CSF into Humanized Mice Enhances the Reconstitution and Maturation of Myeloid Dendritic Cells and the Development of Foxp3+CD4+ T Cells , 2018, Front. Immunol..
[82] Wenwei Hu,et al. Inhibition of HIV early replication by the p53 and its downstream gene p21 , 2018, Virology Journal.
[83] M. Kamata,et al. Correction: Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS , 2018, PLoS Pathogens.
[84] S. Baig,et al. Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins , 2018, Clinical Epigenetics.
[85] D. Grimm,et al. Synthetic AAV/CRISPR vectors for blocking HIV‐1 expression in persistently infected astrocytes , 2018, Glia.
[86] Sigrid A. Langhans. Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning , 2018, Front. Pharmacol..
[87] J. Karn,et al. HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency , 2017, Journal of NeuroVirology.
[88] M. Tremblay,et al. Contrasting effect of the latency-reversing agents bryostatin-1 and JQ1 on astrocyte-mediated neuroinflammation and brain neutrophil invasion , 2017, Journal of Neuroinflammation.
[89] P. Benaroch,et al. Myeloid Cell Interaction with HIV: A Complex Relationship , 2017, Front. Immunol..
[90] E. Eugenin,et al. HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim , 2017, Scientific Reports.
[91] C. Van Lint,et al. Molecular Control of HIV and SIV Latency. , 2017, Current topics in microbiology and immunology.
[92] Arnold R. Kriegstein,et al. The use of brain organoids to investigate neural development and disease , 2017, Nature Reviews Neuroscience.
[93] H. Gendelman,et al. Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains , 2017, Disease Models & Mechanisms.
[94] F. Kashanchi,et al. Exosomes from uninfected cells activate transcription of latent HIV-1 , 2017, The Journal of Biological Chemistry.
[95] K. Brennand,et al. An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells , 2017, bioRxiv.
[96] Hans Clevers,et al. Disease Modeling in Stem Cell-Derived 3D Organoid Systems. , 2017, Trends in molecular medicine.
[97] Daniel R. Berger,et al. Cell diversity and network dynamics in photosensitive human brain organoids , 2017, Nature.
[98] Michael D. Cahalan,et al. iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases , 2017, Neuron.
[99] Chih-Ming Ho,et al. Directing three-dimensional multicellular morphogenesis by self-organization of vascular mesenchymal cells in hyaluronic acid hydrogels , 2017, Journal of biological engineering.
[100] J. Nascimento,et al. Derivation of Functional Human Astrocytes from Cerebral Organoids , 2017, Scientific Reports.
[101] C. Sabin,et al. Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative patients , 2017, AIDS.
[102] Q. Sattentau,et al. Astrocytes Resist HIV-1 Fusion but Engulf Infected Macrophage Material , 2017, Cell reports.
[103] S. Spector,et al. Development and characterization of a human microglia cell model of HIV-1 infection , 2016, Journal of NeuroVirology.
[104] Steven C George,et al. A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications. , 2017, Lab on a chip.
[105] Abraham J. Kandathil,et al. Are T cells the only HIV-1 reservoir? , 2016, Retrovirology.
[106] R. Siliciano,et al. Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques , 2016, AIDS.
[107] L. Smirnova,et al. A Human Brain Microphysiological System Derived from Induced Pluripotent Stem Cells to Study Neurological Diseases and Toxicity , 2016, ALTEX.
[108] J. Karn,et al. Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system , 2016, Journal of NeuroVirology.
[109] C. Van Lint,et al. HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1 , 2016, Scientific Reports.
[110] G. Fogel,et al. HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads , 2016, Journal of Virology.
[111] Konrad Scheffler,et al. Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy , 2016, Virus evolution.
[112] S. Horvath,et al. Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders , 2016, Journal of NeuroVirology.
[113] David W. Nauen,et al. Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure , 2016, Cell.
[114] Carolyn M. Scott,et al. Rapid Induction of Cerebral Organoids From Human Induced Pluripotent Stem Cells Using a Chemically Defined Hydrogel and Defined Cell Culture Medium , 2016, Stem cells translational medicine.
[115] P. Garcez,et al. Zika virus impairs growth in human neurospheres and brain organoids , 2016, Science.
[116] D. Fuchs,et al. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers. , 2016, AIDS research and human retroviruses.
[117] A. Kim,et al. Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier , 2016, Current pharmaceutical design.
[118] J. McCann,et al. KAP1 Recruitment of the 7SK snRNP Complex to Promoters Enables Transcription Elongation by RNA Polymerase II. , 2016, Molecular cell.
[119] M. Churchill,et al. Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells , 2016, Journal of NeuroVirology.
[120] R. Siliciano,et al. HIV reservoirs: what, where and how to target them , 2015, Nature Reviews Microbiology.
[121] C. Van Lint,et al. Epigenetic control of HIV-1 post integration latency: implications for therapy , 2015, Clinical Epigenetics.
[122] G. Pantaleo,et al. The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo , 2015, PLoS pathogens.
[123] A. Chauhan. Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent. , 2015, Microbes and infection.
[124] M. Churchill,et al. CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies , 2015, Molecular Psychiatry.
[125] S. Álvarez,et al. Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-ĸB-dependent mechanism , 2015, Scientific Reports.
[126] V. Fossati,et al. Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells , 2015, Nature Protocols.
[127] Arsène Burny,et al. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression , 2015, PLoS pathogens.
[128] Tao Wu,et al. Progress and challenges in the use of latent HIV-1 reactivating agents , 2015, Acta Pharmacologica Sinica.
[129] M. Salemi,et al. SIV encephalitis lesions are composed of CD163(+) macrophages present in the central nervous system during early SIV infection and SIV-positive macrophages recruited terminally with AIDS. , 2015, The American journal of pathology.
[130] J. Garcia,et al. Humanized mouse models for HIV-1 infection of the CNS , 2015, Journal of NeuroVirology.
[131] D. Geschwind,et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture , 2015, Nature Methods.
[132] M. Wainberg,et al. Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis , 2015, Retrovirology.
[133] Johnny J. He,et al. Cell–cell contact viral transfer contributes to HIV infection and persistence in astrocytes , 2015, Journal of NeuroVirology.
[134] R. Siliciano,et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations , 2015, Nature.
[135] S. Spector,et al. Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1* , 2014, The Journal of Biological Chemistry.
[136] A. Epstein,et al. Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice , 2014, Molecular Neurodegeneration.
[137] D. Margolis,et al. Eradicating HIV-1 infection: seeking to clear a persistent pathogen , 2014, Nature Reviews Microbiology.
[138] Jon W. Johnson,et al. Large-scale generation of human iPSC-derived neural stem cells/early neural progenitor cells and their neuronal differentiation , 2014, Organogenesis.
[139] R. Siliciano,et al. Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1. , 2014, The Journal of allergy and clinical immunology.
[140] Jinyan Liu,et al. Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys , 2014, Nature.
[141] C. Schwartz,et al. The Many Lives of CTIP2: From AIDS to Cancer and Cardiac Hypertrophy , 2014, Journal of cellular physiology.
[142] Kholoud Porter,et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy , 2014, AIDS.
[143] C. Passaes,et al. HIV cure research: advances and prospects. , 2014, Virology.
[144] J. Karn,et al. Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure. , 2014, Virology.
[145] M. Churchill,et al. HIV-1 Entry and Trans-Infection of Astrocytes Involves CD81 Vesicles , 2014, PloS one.
[146] D. Margolis,et al. Emerging strategies to deplete the HIV reservoir , 2014, Current opinion in infectious diseases.
[147] P. Mallon. Impact of nucleoside reverse transcriptase inhibitors on coronary heart disease. , 2014, Reviews in cardiovascular medicine.
[148] R. Johnstone,et al. New and emerging HDAC inhibitors for cancer treatment. , 2014, The Journal of clinical investigation.
[149] L. Al-Harthi,et al. Epigenetic Regulation of HIV-1 Latency in Astrocytes , 2013, Journal of Virology.
[150] A. Debnath,et al. Dual-acting stapled peptides target both HIV-1 entry and assembly , 2013, Retrovirology.
[151] W. Greene,et al. An Integrated Overview of HIV-1 Latency , 2013, Cell.
[152] Madeline A. Lancaster,et al. Cerebral organoids model human brain development and microcephaly , 2013, Nature.
[153] F. Dequiedt,et al. CTIP2 is a negative regulator of P-TEFb , 2013, Proceedings of the National Academy of Sciences.
[154] Alessandro Marcello,et al. HIV-1 transcription and latency: an update , 2013, Retrovirology.
[155] E. Verdin,et al. Reactivation of latent HIV by histone deacetylase inhibitors. , 2013, Trends in microbiology.
[156] M. Benkirane,et al. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. , 2013, Cell reports.
[157] E. Masliah,et al. Molecular and pathologic insights from latent HIV-1 infection in the human brain , 2013, Neurology.
[158] J. Martinez-Picado,et al. Attacking the HIV Reservoir from the Immune and Viral Perspective , 2013, Current HIV/AIDS Reports.
[159] A. Rice,et al. Cyclin T1 and CDK9 T-Loop Phosphorylation Are Downregulated during Establishment of HIV-1 Latency in Primary Resting Memory CD4+ T Cells , 2012, Journal of Virology.
[160] F. J. Livesey,et al. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks , 2012, Nature Protocols.
[161] R. Fromentin,et al. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription. , 2012, Cell host & microbe.
[162] F. Bushman,et al. Directly Infected Resting CD4+T Cells Can Produce HIV Gag without Spreading Infection in a Model of HIV Latency , 2012, PLoS pathogens.
[163] T. Chun,et al. Paucity of HIV DNA Methylation in Latently Infected, Resting CD4+ T Cells from Infected Individuals Receiving Antiretroviral Therapy , 2012, Journal of Virology.
[164] E. V. Bockstaele,et al. HIV-1 Tat neurotoxicity: A model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes , 2012, Neurobiology of Disease.
[165] Andrew P. Rice,et al. Regulation of Cyclin T1 and HIV-1 Replication by MicroRNAs in Resting CD4+ T Lymphocytes , 2011, Journal of Virology.
[166] C. Van Lint,et al. LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing , 2011, Nucleic acids research.
[167] H. Xiong,et al. HIV-1gp120 Induces Neuronal Apoptosis through Enhancement of 4-Aminopyridine-Senstive Outward K+ Currents , 2011, PloS one.
[168] J. Bell,et al. Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals. , 2011, The American journal of pathology.
[169] Jonathan Karn,et al. T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway. , 2011, Journal of molecular biology.
[170] J. Karn,et al. Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2 , 2011, Journal of Virology.
[171] J. Clements,et al. Eradication of HIV from the brain: reasons for pause. , 2011, AIDS.
[172] H. Fox,et al. MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease , 2010, Cell Death and Disease.
[173] J. Clements,et al. Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. , 2010, The Journal of infectious diseases.
[174] K. Jeang,et al. Human cellular restriction factors that target HIV-1 replication , 2009, BMC medicine.
[175] S. Burma,et al. Distinct roles of ATR and DNA‐PKcs in triggering DNA damage responses in ATM‐deficient cells , 2009, EMBO reports.
[176] E. Verdin,et al. Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation , 2009, PLoS pathogens.
[177] J. Dai,et al. Human Immunodeficiency Virus Integrates Directly into Naïve Resting CD4+ T Cells but Enters Naïve Cells Less Efficiently than Memory Cells , 2009, Journal of Virology.
[178] E. Paskaleva,et al. BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex. , 2008, Virology.
[179] D. Greiner,et al. Creation of “Humanized” Mice to Study Human Immunity , 2008, Current protocols in immunology.
[180] Dongyang Yu,et al. Human macrophages support persistent transcription from unintegrated HIV-1 DNA. , 2008, Virology.
[181] D. Nickle,et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. , 2008, The Journal of infectious diseases.
[182] Y. Yen,et al. Role for KAP1 Serine 824 Phosphorylation and Sumoylation/Desumoylation Switch in Regulating KAP1-mediated Transcriptional Repression* , 2007, Journal of Biological Chemistry.
[183] F. Dequiedt,et al. Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencing , 2007, The EMBO journal.
[184] A. Knezevich,et al. Suv39H1 and HP1γ are responsible for chromatin‐mediated HIV‐1 transcriptional silencing and post‐integration latency , 2007, The EMBO journal.
[185] D. Dormont,et al. Characterization of human monocyte‐derived microglia‐like cells , 2006, Glia.
[186] A. Pol. Viral infections in the developing and mature brain , 2006, Trends in Neurosciences.
[187] M. Churchill,et al. Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues , 2006, Journal of NeuroVirology.
[188] J. Clements,et al. Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model. , 2006, The Journal of infectious diseases.
[189] M. Pazin,et al. Histone H4-K16 Acetylation Controls Chromatin Structure and Protein Interactions , 2006, Science.
[190] Axel Imhof,et al. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9 , 2005, Nature chemical biology.
[191] C. Van Lint,et al. COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells , 2005, Nucleic acids research.
[192] A. Brooks,et al. A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[193] K. Morris,et al. Small Interfering RNA-Induced Transcriptional Gene Silencing in Human Cells , 2004, Science.
[194] F. Bushman,et al. RNA interference against retroviruses. , 2004, Virus research.
[195] T. Rana,et al. Inhibition of Human Immunodeficiency Virus Type 1 Replication by RNA Interference Directed against Human Transcription Elongation Factor P-TEFb (CDK9/CyclinT1) , 2004, Journal of Virology.
[196] John J Rossi,et al. Approaches for the sequence-specific knockdown of mRNA , 2003, Nature Biotechnology.
[197] D. Aunis,et al. Regulation of HIV‐1 gene transcription: from lymphocytes to microglial cells , 2003, Journal of leukocyte biology.
[198] M. Leid,et al. COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein. , 2002, The Biochemical journal.
[199] Tara L. Kieffer,et al. Intrinsic Stability of Episomal Circles Formed during Human Immunodeficiency Virus Type 1 Replication , 2002, Journal of Virology.
[200] M. Leid,et al. Isolation of a Novel Family of C2H2 Zinc Finger Proteins Implicated in Transcriptional Repression Mediated by Chicken Ovalbumin Upstream Promoter Transcription Factor (COUP-TF) Orphan Nuclear Receptors* , 2000, The Journal of Biological Chemistry.
[201] D. Aunis,et al. Functional Interactions between C/EBP, Sp1, and COUP-TF Regulate Human Immunodeficiency Virus Type 1 Gene Transcription in Human Brain Cells , 2000, Journal of Virology.
[202] R. Lempicki,et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[203] J. Clements,et al. High Viral Load in the Cerebrospinal Fluid and Brain Correlates with Severity of Simian Immunodeficiency Virus Encephalitis , 1999, Journal of Virology.
[204] Anthony S. Fauci,et al. AIDS: Re-emergence of HIV after stopping therapy , 1999, Nature.
[205] B. Korber,et al. A new classification for HIV-1 , 1998, Nature.
[206] D. Aunis,et al. COUP-TF and Sp1 Interact and Cooperate in the Transcriptional Activation of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat in Human Microglial Cells* , 1997, The Journal of Biological Chemistry.
[207] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[208] E A Emini,et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. , 1997, The New England journal of medicine.
[209] Alan S. Perelson,et al. Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.
[210] M. Bina,et al. Regulation of HIV-1 gene expression by NF-IL6. , 1996, Journal of molecular biology.
[211] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[212] H. Vinters,et al. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients , 1990, Nature.
[213] C. Wiley,et al. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[214] R. Brack-Werner. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. , 1999, AIDS.